VENTOLIN ROTACAPS salbutamol (as sulfate) 200 microgram powder for inhalation strip pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

salbutamol sulfate, Quantity: 241 microgram (Equivalent: salbutamol, Qty 200 microgram)

Available from:

GlaxoSmithKline Australia Pty Ltd

Pharmaceutical form:

Insufflation

Composition:

Excipient Ingredients: lactose monohydrate

Administration route:

Inhalation

Units in package:

128 rotacaps insufflations, 100 rotacaps insufflations

Prescription type:

(S3) Pharmacist Only Medicine

Therapeutic indications:

For the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.Ventolin Rotacaps are indicated for the above conditions in those patients unable to use a pressurised aerosol bronchodilator satisfactorily. Patients most likely to benefit from the use of Rotacaps are: 1. Children from 3 to 6 years of age who are too young to operate a metered aerosol. 2. Patients who have difficulty synchronising deep inhalation with actuation of a metered aerosol. 3. Patients who are sensitive to Freon propellants.

Product summary:

Visual Identification: Hard gelatin caps pale blue opaque caps & clear body containing small amount of powder. Printed on each capsule is "Ventolin 200" in light red ink once on the cap and an arrow on the body. Cartridge hard cap. size No.3.; Container Type: Strip Pack; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Licence status A

Authorization date:

1991-08-13